Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 253

Results For "ENT"

10058 News Found

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Cardioline expands global reach with strategic Cardios acquisition
News | May 01, 2026

Cardioline expands global reach with strategic Cardios acquisition

The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide


Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA
People | May 01, 2026

Microbot Medical Inc. appoints Alon Tamir as VP Sales EMEA

Tamir brings more than 20 years of experience in the medical technology sector


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
Hospitals | May 01, 2026

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi

The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries


Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer
Hospitals | May 01, 2026

Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer

Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership


India's healthcare policymakers call for digital health expansion and system strengthening
Policy | May 01, 2026

India's healthcare policymakers call for digital health expansion and system strengthening

Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms


Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection
Drug Approval | May 01, 2026

Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection

Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada


Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets